Weight loss

Beyond Weight Loss: Reading the GLP-1 Side Effect Profile in Real Numbers A field guide for clinicians who are tired of being shown hazard ratios without denominators.

Volume 1 - Issue 3 (May 2026

The First Oral Carbapenem Arrives - Tebipenem pivoxil (Utebzi): what it is, where it earns its place, and where it absolutely does not

Baxdrostat vs. Spironolactone: A New Mechanism Meets an Old Bargain - THE $5-BILLION QUESTION

IV Iron in Oncology: Time to Rethink Your Default

When the New β-Lactam/β-Lactamase Inhibitors Aren’t Enough

PharmaCompass InPHARMation is for educational purposes only and does not constitute medical advice. Always verify clinical information before applying to patient care. Full Disclaimer | © 2026 PharmaCompass Education, LLC

Read more

The First Oral Carbapenem Arrives - Tebipenem pivoxil (Utebzi): what it is, where it earns its place, and where it absolutely does not

Baxdrostat vs. Spironolactone: A New Mechanism Meets an Old Bargain - THE $5-BILLION QUESTION

IV Iron in Oncology: Time to Rethink Your Default

When the New β-Lactam/β-Lactamase Inhibitors Aren’t Enough